Status:
COMPLETED
Comprehensive Screening for Women at High Genetic Risk for Developing Breast Cancer
Lead Sponsor:
Stanford University
Collaborating Sponsors:
National Institutes of Health (NIH)
United States Department of Defense
Conditions:
Breast Cancer
Eligibility:
FEMALE
25-65 years
Brief Summary
To screen women who are high risk for breast cancer with breast MRI, mammogram and random periareolar fine needle aspiration.
Detailed Description
General Purpose: The purpose of our protocol is develop a comprehensive screening protocol for women at high risk for developing breast cancer in the hopes of detecting breast cancer or it's precursor...
Eligibility Criteria
Inclusion
- Inclusion Criteria:Subjects must be female, between the ages of 25 and 65, or ten years younger than the youngest breast cancer diagnosed in the family, or have no mutation identified but have a greater than 10% risk of developing breast cancer in ten years (based on the Claus Model).
- May have had previous breast or ovarian cancer, but must be at least one year out from treatment of a Stage 1 or early 2 cancer.
Exclusion
Key Trial Info
Start Date :
November 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2007
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00255060
Start Date
November 1 2001
End Date
June 1 2007
Last Update
July 20 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305